CNS Pharmaceuticals Inc (CNSP) — Strategic Asset Allocation Index
CNS Pharmaceuticals Inc (CNSP) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of $3.38K plus long-term investments of $-) total $3.38K, measured against net assets of $2.45 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
CNS Pharmaceuticals Inc Strategic Asset Allocation Index (2019–2021)
This chart shows how CNS Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2021. As of June 2023, the index stands at 0.1%, representing strategic assets of $3.38K against net assets of $2.45 Million USD. Explore CNS Pharmaceuticals Inc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for CNS Pharmaceuticals Inc (2019–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for CNS Pharmaceuticals Inc from 2019 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CNSP company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.2% | $16.11K | $16.11K | $- | $6.62 Million | ▲ +0.1 pp |
| 2020 | 0.2% | $23.43K | $23.43K | $- | $13.95 Million | ▼ -0.1 pp |
| 2019 | 0.2% | $18.16K | $18.16K | $- | $7.60 Million | — |